Frazier Life Sciences Acquisition Corp. II
FLSC · NASDAQ
FLSC key statistics
- Market cap
- —
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 451.28K
- Volume
- 64.42K
- Open price
- $10.29
- High today
- $10.35
- Low today
- $10.26
- 52 Week high
- $10.59
- 52 Week low
- $10.18
Frazier Life Sciences Acquisition Corp. II (FLSC) at a glance
As of Oct 20, 2026, Frazier Life Sciences Acquisition Corp. II (FLSC) shares are priced at $10.27.
Today the stock has traded between $10.26 and $10.35. The current price is 0.1% above the day's low and 0.8% below its high.
Volume so far is 64.42K shares, below the average of 451.28K shares a day.
Over the past year Frazier Life Sciences Acquisition Corp. II has ranged from $10.18 to $10.59, and now sits 22% of the way up that range.
FLSC news
- Press releaseBusiness Wire
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1478+24.20%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- CBDW1606$0.0002−25.00%
- PRSOPeraso$0.5917+54.21%
- FRTTFort Technology$0.6884+28.21%
- CBDLCBD Life Sciences$0.0001−50.00%
- WFFWF Holding$0.0932−3.52%
- NBNDNetBrands$0.0009−22.75%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.51+1.01%
- CTYCITY THERAPEUTICS$20.64−3.82%
- IAMIambic Therapeutics$15.83−3.12%
- AMROAmaero$5.79+3.21%
- TRXBTRex Bio$14.78−0.17%
- RTSNRetension Pharmaceuticals$16.60+1.65%
- PAXGUPine Tree Acquisition$9.99+0.10%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.17−2.60%
- RZAIROZE AI$10.20+0.49%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.